BioWorld
LRRK2 Polyclonal Antibody-BS90809
LRRK2 Polyclonal Antibody-BS90809
Couldn't load pickup availability
LRRK2 Polyclonal Antibody
Sizes: 50µl, 100µl
Catalogue Numbers: BS90809-50, BS90809-100
Product: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Swiss-Prot: Q5S007(Human) Q5S006(Mouse)
Host: Rabbit
Reactivity: Human, Mouse
Applications: ICC IHC
All Applications: ICC:1:50-1:200
IHC:1:50-1:200
Background: Parkinson's disease is a disorder of movement, cognition and emotion. It is characterized pathologically by neuronal degeneration with Lewy bodies, which are cytoplasmic inclusion bodies containing deposits of aggregated proteins. Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause autosomal-dominant parkinsonism, with clinical features of Parkinson's disease and with pleomorphic pathology including deposits of aggregated protein. The LRRK2 protein consists of multiple domains and belongs to the Roco family, a novel group of the Ras/GTPase superfamily. Besides the GTPase (Roc) domain, it contains a predicted kinase domain, with homology to MAP kinase kinase kinases. LRRK2 is localized in the cytoplasm and is associated with cellular membrane structures. The purified LRRK2 protein demonstrates autokinase activity.
Purification and Purity: Peptide affinity purified.
Storage and Stability: Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Specificity: LRRK2 polyclonal antibody detects endogenous levels of LRRK2 protein.
Bioworld Molecular Weight: 286 kDa
Note: For research use only, not for use in diagnostic procedure.
Extra Notes: ICC staining LRRK2 in A549 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS., ICC staining LRRK2 in N2A cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Alternative Name: LRRK2, PARK8, augmented in rheumatoid arthritis 17, AURA17, Dardarin, Leucine rich repeat kinase 2, leucine rich repeat serine threonine protein kinase 2, Leucine-rich repeat serine/threonine-protein kinase 2, LRRK 2, LRRK2, LRRK2, PARK 8, PARK8, RIPK7, ROCO 2, ROCO2,
Immunogen: Peptide.
Conjugate: Unconjugated
Modification: Unmodified